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ABSTRACT
Neuropeptides are small signaling molecules found throughout the nervous
system that influence animal behavior. Using the American lobster, Homarus
americanus, as a model system, this research focused on an allatostatin type-C (AST-C)
peptide, pQIRYHQCYFNPISCF (disulfide bond between underlined cysteine residues),
and a structurally similar crustacean peptide, SYWKQCAFNAVSCFamide. These
neuropeptides influence cardiac muscle contraction patterns and stomatogastric nervous
system activity in the lobster. To understand their roles, this study sought to develop a
method to quantify peptides in the pericardial organ (PO) and other crustacean tissues.
Overall analysis involved microdissection to isolate tissues, tissue extraction, extract
purification and concentration, and analysis by chip-based nano-electrospray ionizationliquid chromatography-mass spectrometry (nanoESI-LC-MS). In the present study,
pQIRYHQCYFNPISCF was identified in the PO. To quantify target peptides, internal
standards were tested as recovery and calibration references. However, experiments with
pQIRYHQCYFNPISCF and other peptides showed evidence of adsorptive losses during
sample preparation and analysis, with improvements in recovery resulting from the use of
isopropanol-prewashed polypropylene vials. Preliminary results also suggested that
introducing polyethylene glycol (PEG) in solution reduced adsorptive losses for
hydrophobic peptides, but may have compromised hydrophilic peptide detection. Future
directions include characterizing other sources of analyte loss and developing techniques
to recover these signals. Since both target peptides as detected in the lobster are posttranslationally modified, other directions include identifying modified and unmodified
forms of these peptides in H. americanus. Ultimately, quantifying AST-C peptides and
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identifying their modified and unmodified forms will help explain how neuropeptides
regulate behavior within the lobster and more complex systems.

viii

INTRODUCTION
1.1 Context of study
Hundreds of signaling molecules called neuropeptides are responsible for
influencing behavior in humans and other animals. Neuropeptides are short α-amino acid
chains found throughout the nervous system. They originate from large precursor
proteins, or prepro-hormones, that are transcribed and translated from genomic genetic
material. These precursor proteins are post-translationally cleaved into several smaller
peptides by enzymatic processes. Like all amino acid chains, neuropeptides consist of a
series of amino acid residues linked by amide bonds (Fig. 1). The side of an unmodified
amino acid chain terminating with an amine group is called the N-terminus; the end with
a carboxylic acid group is the C-terminus. Structures and masses of the twenty amino
acids are presented in Table 1.

N-terminus

C-terminus
Amide bond

Amino acid residue

Fig. 1. Peptide structure. Amino acids are linked by amide bonds, with
the N-terminus given by the amine group and the C-terminus given by the
carboxylic acid. Amino acid identity given by unique side chain (R
group).
Active neuropeptides interact with membrane receptors to control behavior. Some
neuropeptides must be post-translationally modified by enzymatic processes in order to
become bioactive. Post-translational modifications may occur at the N- or C-terminus,
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such as a C-terminal amidation (Fig. 2A). Other modifications may be internal, such as
the linking of two cysteine residues by a disulfide bond (Fig. 2B). Some neuropeptides
are active without being post-translationally modified or being minimally modified
(Perdew, 2007; Hou et al., 2012).
A

B

Fig. 2. Examples of post-translational modifications. (A) C-terminal
amidation via the partial cleavage of a terminal glycine to form a terminal
amide. (B) Disulfide bond formation between two cysteine residues. Both
conversions are mediated by enzymes in the organism.
Current research involves investigating neuropeptide interactions and the
mechanisms through which they regulate biological activity. Since the purpose of having
hundreds of neuropeptides in a given system is unknown, determining the unique
functions of a given peptide will help elucidate their functional roles within a system.
Whereas mammals have highly complex nervous systems, crustaceans have far fewer
neurons and neuropeptides and are appropriate model systems for neuropeptide research.
The American lobster, Homarus americanus has been used for studies of invertebrate
neural circuitry and peptide modulation in the stomatogastric and cardiac nervous
2

systems (Ma et al., 2009; Christie et al., 2010). In particular, after being removed from
the animal, the stomatogastric nervous system and heart remain intact and functional.
This is another advantage of using H. americanus as a model system and greatly
facilitates the analysis of neuropeptide effects (DeKeyser and Li, 2006; Christie et al.,
2010).
Within these systems, allatostatin type-C (AST-C) peptides are of particular
interest due to their influence on cardiac muscle contraction patterns in H. americanus.
Originally identified in insects as juvenile hormone production inhibitors in the corpora
allata, the AST-C family is distinguished by a –PISCF sequence at the unblocked Cterminus, a pyroglutamate group at the N-terminus, and a disulfide bond linking the Cys7
and Cys14 residues (Christie et al., 2010).
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Table 1. Amino acid abbreviations, residue masses, and side chain structures. Adapted
from Luppino 2010.
Amino Acid
Alanine

Residue Mass
(Da)
71.03711

Abbreviation
Ala

Code
A

Arginine

Arg

R

156.10111

Asparagine

Asn

N

114.04293

Aspartate

Asp

D

115.02694

Cystine

Cys

C

103.00918

Glutamate

Glu

E

129.04259

Glutamine

Gln

Q

128.05858

Glycine

Gly

G

57.02146

Histidine

His

H

137.05891

Isoleucine

Ile

I

113.08406

Leucine
Lysine
Methionine

Leu
Lys
Met

L
K
M

113.08406
128.09496
131.04048

Phenylalanine

Phe

F

147.06841

Proline

Pro

P

97.05276

Serine

Ser

S

87.03203

Threonine

Thr

T

101.04768

Tryptophan

Trp

W

186.07931

Tyrosine

Tyr

Y

163.06333

Valine

Val

V

99.06841
4

Side Chain Structure

1.2 Neuropeptides of interest
The neuropeptide pQIRYHQCYFNPISCF (disulfide bond between underlined
Cys7 and Cys14) was the first type-C allatostatin to be identified in a non-insect and has
been found to be widely distributed throughout the H. americanus nervous system
(Stemmler et al., 2010). This peptide was found in the eyestalk, where many
neuropeptides are manufactured and stored, and in the pericardial organ (PO), a tissue
that delivers neuropeptides to cardiac muscle (Fig. 3) (Christie et al., 2010). Visualization
by immunohistochemistry shows that pQIRYHQCYFNPISCF in the PO localizes to the
nerve projecting from thoracic ganglion and the neurosecretory endings (Fig. 4).

Fig. 3. Crustacean nervous system. (A) Whole body shown with (B)
thoracic nervous system highlighted. This study focuses on the pericardial
organ (PO) (dark orange), a tissue that delivers neuropeptides to cardiac
muscle. Adapted from (Skiebe, 2003).
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ASTC-real
Neurosecretory Endings

Nerve from thoracic ganglion

Fig. 4. Target peptide visualization in the PO. pQIRYHQCYFNPISCF
(green) and SYWKQCAFNAVSCFamide visualization in the PO by
immunohistochemistry (bottom) with corresponding schematic drawing (top).
pQIRYHQCYFNPISCF localizes to the nerve projecting from thoracic
ganglion and the neurosecretory endings. No notable quantities of
SYWKQCAFNAVSCFamide are found in the PO; the Dickinson Lab
concluded that the red staining was primarily nonspecific. Adapted from
figures provided by P. Dickinson and E. Dickinson.
Similar to many other neuropeptides, pQIRYHQCYFNPISCF is posttranslationally modified from its original form, QIRYHQCYFNPISCF (Fig. 5A).
Through enzymatic processes, the N-terminal glutamine is converted to a pyroglutamate
group and the hydrogens on the cysteine R-groups are lost to form a disulfide bridge
linking these two internal Cys6 and Cys13 residues. The final processed peptide is
pQIRYHQCYFNPISCF (Fig. 5B). It is unknown whether this peptide is present in the
animal in any unprocessed forms, such as one having an unmodified N-terminus or a
reduced form lacking a disulfide bond, or whether these forms are bioactive.
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A

B

QIRYHQCYFNPISCF
(before modification)

pQIRYHQCYFNPISCF
(after modification)

C

D

SYWKQCAFNAVSCFG
(before modification)

SYWKQCAFNAVSCFamide
(after modification)

Fig. 5. Target peptide post-translational modification. (A) unmodified
QIRYHQCYFNPISCF and (B) pQIRYHQCYFNPISCF after the
formation of pyroglutamate at the N-terminus and a disulfide bond linking
Cys7 and Cys13. (C) unmodified SYWKQCAFNAVSCFG and (D)
SYWKQCAFNAVSCFamide after C-terminal amidation and the
formation of a disulfide bond linking Cys6 and Cys13.
In addition to pQIRYHQCYFNPISCF, a structurally similar peptide has been
identified in H. americanus as SYWKQCAFNAVSCFamide. This peptide is initially
translated as SYWKQCAFNAVSCFG (Fig. 5C). Like pQIRYHQCYFNPISCF, it
undergoes enzymatic post-translational modification that converts the C-terminal glycine
to an amide group and forms a disulfide bond bridging the internal Cys6 and Cys13
residues. Its N-terminus is left unblocked and the resulting processed form is
SYWKQCAFNAVSCFamide (Fig. 5D). Both pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide influence pyloric rhythm frequency in the stomatogastric
nervous system and cardiac muscle contraction patterns (Dickinson et al., 2009; Ma et al.,
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2009; Christie et al., 2010). It is also unknown whether any unmodified forms, such as
one having an unamidated C-terminus or a reduced form lacking a disulfide bond, are
present in the animal or whether they are bioactive.
It has been observed that cardiac muscle contractions of different lobsters of the
same species exhibit two different responses to applications of pQIRYHQCYFNPISCF
and SYWKQCAFNAVSCFamide. This response is unusual, as two animals of a single
species generally respond similarly to a given treatment; however, when the semi-intact
heart is exposed to pQIRYHQCYFNPISCF, the amplitude of cardiac muscle contractions
increases in some lobsters and decreases in others. Cardiac muscle contraction frequency
consistently decreases across preparations. This inter-animal variability and the structural
similarity between pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide make
these crustacean peptides interesting candidates for the study of neuropeptides
(Wiwatpanit et al., 2012). Currently, post-translational modifications of
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide have been identified (Fig. 5),
but other modified forms of these peptides are unknown.
1.3 Peptide characterization by liquid chromatography-mass spectrometry (LC-MS)
and tandem mass spectrometry (MS/MS)
In this study, we were working to develop a method to identify and quantify
modified and unmodified forms of pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide in H. americanus eyestalk and PO tissue extracts using
internal standards and chip-based nano-electrospray ionization-liquid chromatographymass spectrometry (nanoESI-LC-MS). NanoESI LC-MS is a highly sensitive technique
that allows for the detection of femtomolar amounts of peptides in small sample volumes
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while preserving detection accuracy, robustness, and precision (Karas et al., 2000; Yin
and Killeen, 2007). Overall, samples may be separated by chromatography and
subsequently identified by mass using mass spectrometry by measuring their mass-tocharge ratio (m/z). Peptides can also be sequenced by fragmenting target analytes and
identifying the m/z values associated with each fragment using tandem mass
spectrometry (MS/MS).
The first step of this technique is high performance liquid chromatography
(HPLC), which separates liquid sample components based on properties such as their
size, charge, and interactions with the hydrophobic stationary phase column (Ho et al.,
2003). In a conventional LC-MS instrument, the sample travels through a hydrophobic
separation column to separate components. This column is connected to an ESI ionization
source that nebulizes and ionizes the sample for MS analysis. However, the connections
between the columns, capillaries, and valves involved in this process can leak and cause
high sample loss (Yin and Killeen, 2007). To overcome such challenges posed by
conventional LC-MS systems, an Agilent HPLC-Chip has been used for both HPLC
sample separation and nanoelectrospray ionization (nanoESI) in this study. The chip is a
multilayer polyimide film that eliminates leaky connectors and adapters, thereby
maximizing sensitivity and ease of use. The liquid sample is injected and flows onto an
enrichment column in the chip to be concentrated and washed to eliminate contaminants.
When flow is directed from the enrichment column to the analytical column by rotation
of a rotary valve, the hydrophobic analytical column separates the sample components,
which travel through the column at different rates and elute at characteristic retention
times. Lastly, a nanoESI tip is used for sample ionization before MS analysis (Yin and
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Killeen, 2007). Liquid chromatography with MS detection yields a chromatogram of
instrument response vs. retention time, which allows sample components to be
distinguished based on elution time.
For mass analysis (Fig. 6), the liquid sample must be converted into gas phase
ions by electrospray ionization. The liquid is nebulized from the nanoelectrospray tip on
the HPLC-Chip using an electric field to yield highly charged droplets that are driven
electrostatically to the mass analyzer inlet. Nitrogen gas is used to dry the sample so that
the solvent evaporates and only the analyte ions reach the mass spectrometer. Since the
mass spectrometer identifies analytes by their mass-to-charge (m/z) ratios, very large
molecules can be detected by this technique because ESI allows for the formation of
multiply charged ions. For example, a protein with molecular weight of 10,000 Da that is
charged by one, two, three, four, or five protons would be detected as having an m/z ratio
of 10,001, 5001, 3334, 2501, or 2001 Da, respectively. This greatly widens the mass
range of analytes that can be detected using this technique (Siuzdak, 1996).
Mass spectrometry uses a mass analyzer and detector to determine the m/z ratio of
the analyte ions. For the quadrupole time-of-flight (Q-TOF) mass analyzer used in this
study, ions travel from the ionization region through eight metal rods called an octupole
ion guide that ensures transmission of nearly all the target ions. The ions then enter the
quadrupole mass filter, which consists of four rods that either can be used to transmit a
wide range of ions to the TOF mass analyzer (MS mode), or can select a precursor ion for
dissociation (MS/MS mode). In either mode, the ions are injected into the TOF mass
analyzer, where they are accelerated to the same kinetic energy and mass analyzed by the
differences in velocity resulting from differences in m/z. Using differences in flight times,

10

the mass analyzer determines the m/z of each ion at high resolution. Ultimately, spectra of
abundance vs. m/z are collected at various retention times. Peak patterns in the MS
spectrum reveal the charge state (number of added protons) for a given species and allow
for the determination of the mass of the ion (Williamson and Bartlett, 2007); the exact
mass measurements permit highly specific identifications based upon elemental
compositional differences.
A

B

Fig. 6. Schematic diagrams of a mass spectrometer. (A) Block diagram
of a mass spectrometer. Adapted from Kinter & Sherman 2000. HPLCchip involved in both the separation of sample components by HPLC and
ionization by nanoESI. (B) Schematic diagram of Q-TOF mass analyzer.
Adapted from (Vollmer et al., 2011).
In order to determine the chemical identity and amino acid sequence of
neuropeptides, tandem mass spectrometry (MS/MS) is used to sequence target molecules.
After selecting a precursor using the quadrupole mass filter, the precursor ion is
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accelerated into the hexapole collision cell (Fig. 6). Here, the accelerated ion collides
with gas molecules (N2) and the collisions produce product ions and uncharged
fragments. The product ions are analyzed in TOF mass analyzer to determine their m/z
and infer their masses (Kinter and Sherman, 2000).
To characterize pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide by
MS and MS/MS, their measured m/z values will be compared to their expected exact
masses and sequences. Based on the peptide sequences, their neutral exact masses are
expected to be 1898.823 Da and 1649.712 Da, respectively. Using ESI, which allows for
the formation of multiply charged species, all available basic sites on a peptide are
expected to be protonated. Peptides are typically protonated at the N-terminal amine and
at the basic residues lysine (K), arginine (R), and histidine (H) (Kinter and Sherman,
2000). Since a pyroglutamate group is not expected to be basic enough to be protonated,
pQIRYHQCYFNPISCF is expected to be protonated at the Arg3 and His5 residues.
SYWKQCAFNAVSCFamide is expected to be protonated at the N-terminus and Lys4
residue. In addition to MS mass measurements, MS/MS analysis should confirm these
amino acid sequences. Unmodified peptides will show retention time, m/z, and MS/MS
mass spectral differences relative to the modified peptides.
1.4 Peptide quantification by internal standard
Internal standards have been used in previous studies to quantify peptides in
biological tissues. Calibration using internal standards is a powerful quantification
technique that can account for sample loss occurring throughout the tissue extraction and
sample preparation when the internal standards are added at the beginning of the sample
preparation process. Isotopically labeled standards are the most accurate because they
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behave essentially identically to the target peptides. However, structurally-related
analogue internal standards may also be used for quantification, as these are more
accessible and economical and can be selected to mimic the behavior of the target
peptides (Bronsema et al., 2013).
1.5 Quantifying AST-C peptides in H. americanus
Methods for quantifying pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide will be explored using structurally similar internal
standards. In order to make use of an internal standard, the amount of internal standard
that must be added to the initial sample must be determined. Ideally, the amount of
internal standard detected will be comparable to the amount of target peptide detected.
However, the concentrations of AST-C peptides in crustacean tissue have not yet been
quantified and may vary from animal to animal, making it difficult to apply internal
standard techniques to the analysis. To address this challenge, a mixture of at least three
internal standards will be added to the tissue extraction solvent. The concentration of
each internal standard will differ by one order of magnitude. This way, the target peptide
signal can be compared to the internal standard signal that is closest in intensity in order
to maximize accuracy (Fig. 7).
To determine peptide concentrations following tissue extraction and sample
preparation, the internal standard instrument responses will be compared to the known
internal standard concentrations added to the extraction solvent. Using a calibration curve
constructed from calibration data, the concentrations of pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide originally present in the tissue will be determined from the
detected concentrations of these target peptides. Optimal internal standard concentrations
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will be determined empirically by estimating target peptide levels and testing for standard
concentrations that maximize signal reliability and consistency. Ideally, the target peptide
concentration will be near the center of the internal standard concentration range.

Fig. 7. Peptide quantification by internal standard.
Determination of pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide concentrations based on amounts of
various internal standards. Chromatographic peak intensity for
target peptides may vary over a wide range and will be compared
to the internal standard peak with most similar intensity.
1.6 Project goals
In this study, peptide extraction and detection will be optimized and techniques
will be tested to identify and quantify pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide in H. americanus tissue. Both peptides will be analyzed in
the eyestalk and the former will also be analyzed in the PO. To identify target peptides,
standards will first be characterized by liquid chromatography-mass spectrometry (LCMS, described in more detail below). Eyestalk and PO tissue extracts will be analyzed for
these peptides and delipidation techniques will be tested to reduce phospholipid
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contamination. Ultimately, techniques for quantifying peptides by internal standard and
reducing peptide signal loss will be explored.
EXPERIMENTAL
2.1 Instrumentation
For chromatography and nano-electrospray ionization (nanoESI) for peptide
standards and tissue extracts, a 1260 Chip Cube system (Agilent Technologies) and a
ProtID-chip with a 40-nL enrichment column and a 150 mm x 75 m analytical column
(Agilent Technologies) were used. The enrichment and analytical columns were packed
with 300-Å, 5-m particles with C18 stationary phase. The mobile phases were 0.1%
formic acid (FA) with 2% water in acetonitrile (ACN) and 0.1% FA in water, 300-nL/min
flow rate; 0.01 to 1.0 L injected. The mobile phase gradient was optimized for standard
characterization and sample analysis.
A 6530 quadrupole time-of-flight (Q-TOF) mass analyzer (Agilent Technologies,
Santa Clara, CA) was used for mass spectrometric analysis. Mass spectra were collected
in positive (or negative) ion mode; the ionization voltage ranged from 1750 -1950 V, the
fragmentor voltage was 175 V and the source temperature was held at 300 °C. Spectra
were internally calibrated using reference compounds. Methyl stearate (C17H35CO2CH3)
and hexakis (1H, 1H, 4H-hexafluorobutyloxy) phosphazine (HP-1221;
C24H18O6N3P3F36), continuously infused and detected as [M+H]+, were used to internally
calibrate all spectra in positive ion mode.
2.2 Animals
American lobsters (Homarus americanus) were purchased from Gurnet Trading
Co. and kept in recirculating seawater tanks at 10-12 C (Brunswick, ME).
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2.3 Chemicals and sample storage and analysis vials
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide were synthesized by
GenScript (Piscataway, NJ, purities 95.7% and 95.1%, respectively). An extraction
solvent of 85% acetone (SigmaAldrich, > 99%), 13% deionized water, and 2% HCl
(Fisherbrand; reagent grade) as a %[v/v] mixture was used for some tissue samples. For
other samples, an extraction solvent of solvent 64% methanol (Fischer Scientific, > 99%),
29% deionized water, and 7% acetic acid (SigmaAldrich, > 99%) as a %[v/v] mixture
was used. Dithiothreitol (DTT) (SigmaAldrich, > 99%) was used to reduce disulfide
bonds in peptide standards. Chloroform (Cambridge Isotope Laboratories; NMR-grade
13

CDCl3) was used for delipidation. [Arg8]vasotocin, [Lys8]vasopressin,

[Arg8]vasopressin, and oxytocin (American Peptide Co., > 99%) were selected as internal
standards.
2.4 Peptide standard preparation and characterization
To characterize pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide, 10
µM and 5 µM standards of each peptide were prepared using a serial dilution. First, 10-3
M stock solutions in water were diluted to 10 µM in plastic vials. These solutions were
diluted to 5 µM in conical polypropylene vials for LC-MS analysis. Serial dilutions were
also performed using low-retention plastic tubes and non-serial dilutions were prepared
by diluting peptide standards directly into conical polypropylene vials for analysis.
2.5 Disulfide bond reduction by dithiothreitol (DTT)
To reduce the disulfide bond linking the cysteine residues in the target peptide, 66
µL of 0.2 M dithiothreitol (DTT) was added to 20 µL of 100 µM
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SYWKQCAFNAVSCFamide in a polypropylene vial. The reaction was allowed to
proceed at room temperature for 15 min.
2.6 Tissue extraction
Tissues (eyestalks and POs) were removed from the lobster using microdissection
techniques and were immediately heated at 100 °C for 5 min in 50 µL of preheated
extraction solvent in 0.6 mL low-retention tube (rinsed 3 x 200 µL of extraction solvent).
Both an acetone solvent (85% acetone/13% deionized water/2% hydrochloric acid) and
methanol solvent (64% methanol/29% water/7% acetic acid) were tested. The tissue was
homogenized either by manually compressing and grinding the sample with a 0.2-mL
low-retention tube (outside rinsed with acetone extraction solvent) or by using a
polypropylene pellet pestle with cordless motor (SigmaAldrich). Tissues were sonicated
for 5 min and centrifuged for 10 min at 10.1 g. The supernatant and an additional 100 µL
of extraction solvent were filtered through a 0.45-µm filter (rinsed 3 x 300 µL of
extraction solvent and centrifuged for 15 s per wash at 10.1 g) and centrifuged for 1 min
at 10.1 g. An additional 100 µL of extraction solvent was drawn through the filter twice,
centrifuged for 60 s, and the filtrate was vacuum dried. Samples not to be immediately
analyzed were stored at -80 °C at this step. For analysis, vacuum dried samples were
reconstituted in 50 µL of 25% acetonitrile (ACN), sonicated 5 min, and transferred to a
conical polypropylene vial. Samples were analyzed by LC-MS.
2.7 Delipidation
A delipidation approach was tested by adding 50 µL of chloroform to the 350 µL
filtrate before vacuum drying. The mixture was pipetted several times to mix, sonicated,
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and let sit to separate. The bottom chloroform layer was removed and the resulting
aqueous layer was vacuum dried and analyzed by LC-MS.
2.8 Detection limit assessment
Both target peptide standards were added to separate 40 µL aliquots of pooled
eyestalk extracts at concentrations of 500, 100, 50, 10 and 1 nM. Samples were replicated
so that two equivalent samples were analyzed for one target peptide at a single
concentration. Serial dilutions were prepared from 10-3 M target peptide solutions in
water in low-retention tubes. Chromatographic peaks were integrated and plotted as a
function of peptide concentration to evaluate signal-to-concentration linearity.
2.9 Internal Standard Characterization
Solutions of [Arg8]vasotocin, [Lys8]vasopressin, [Arg8]vasopressin, and oxytocin
in water were prepared and characterized by chromatography and MS as described in
Section 2.4. Mixtures of 1, 10, 100, and 1000 nM of each of these standards were then
characterized, followed by mixtures of 100 nM of the four internal standards and the two
target peptides. Multiple preparations of 100 and 10 nM mixtures of [Arg8]vasotocin and
the two target peptides were also analyzed at an injection volume of 1.0 µL. Lastly, the
mixtures shown in Table 2 were analyzed by chromatography to determine an internal
standard concentration gradient that would allow for the reliable detection of all peptides.
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Table 2. Internal standard mixture concentrations for preliminary concentration gradient
determination
[Arg8]vasotocin
Mixture (M)
1
None
2
1.00 x 10-4
3
1.00 x 10-5
4
1.00 x 10-6

[Lys8]vasopressin
(M)
1.00 x 10-4
1.00 x 10-5
1.00 x 10-6
1.00 x 10-7

[Arg8]vasopressin
(M)
1.00 x 10-5
1.00 x 10-6
1.00 x 10-7
1.00 x 10-8

oxytocin (M)
1.00 x 10-6
1.00 x 10-7
1.00 x 10-8
1.00 x 10-9

2.10 Dilution preparation with vial prewashing
Both polypropylene and glass vials were prewashed with water, 25% ACN, and
isopropanol (all purchased from Fisher Scientific, LC-MS grade) to test the effectiveness
of these solvents at preventing adsorptive losses. Each vial was washed 3 x 500 µL of
each solvent and dried in open air overnight to ensure solvent evaporation. After these
tests, all polypropylene vials used for analysis were prewashed by full submersion in
isopropanol in a beaker and sonication for 5 min. The isopropanol was then discarded and
this washing was repeated. Vials dried overnight in the beaker, which was partially
covered in aluminum foil to prevent contamination while allowing evaporation. For
subsequent experiments testing dilution preparation techniques, pipette tips and lowretention tubes were prewashed by repeated isopropanol submersion, sonication, and
drying as described.
2.11 Dilution preparation to test signal recovery
Solutions of seven peptides at equal concentrations were prepared from standards
synthesized by GenScript (Piscataway, NJ, purity shown in parentheses): RTVGGFA
(99.3%), RAAFGFA (99.4%), AST-B (> 95%), RTVFGFA (99.8%),
AFDEIDRSGFGFA (97.8%), CLDH (95.3%), and pQIRYHQCYFNPISCF. All 10-3 M
stock solutions were stored at –20°C and were fully thawed and sonicated for 5 min
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before diluting. Samples were prepared by diluting a 10-4 M mixture of all peptides to be
analyzed in isopropanol-washed low-retention tubes.
RESULTS AND DISCUSSION
3.1 Peptide standard characterization (oxidized and reduced forms)
Standards of pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide and their
reduced forms were successfully characterized by chromatography, MS, and MS/MS.
Based on the predicted target peptide sequences, the expected masses for the singly-,
doubly-, and triply-charged states were calculated (Table 3). For 10 µM peptide solutions
(prepared by diluting stock solutions directly into polypropylene vials), the
chromatograms showed intense chromatographic peaks (Fig. 8A and C) whose MS
spectra matched the expected masses (Fig. 8B and D) for each standard. Using the
specified mobile phase gradient, pQIRYHQCYFNPISCF eluted at 7.02 min (Fig. 8A)
and SYWKQCAFNAVSCFamide at 6.37 min (Fig. 8C). pQIRYHQCYFNPISCF
consistently eluted after SYWKQCAFNAVSCFamide. Since modifications to the mobile
phase gradient changed elution patterns, peptide retention times varied between analyses.
Nonetheless, pQIRYHQCYFNPISCF consistently eluted after
SYWKQCAFNAVSCFamide. This was consistent with expectations because
pQIRYHQCYFNPISCF is the larger peptide, as indicated by its higher mass. This later
elution time also suggests that pQIRYHQCYFNPISCF is more hydrophobic, which can
be attributed to its pyroglutamate group. Upon pyroglutamate formation by the
cyclization of the N-terminal glutamic acid, two hydrophilic amine groups are lost
(Schlenzig et al., 2009). This increases the hydrophobicity of pQIRYHQCYFNPISCF
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and, along with its larger size, causes greater retention by the hydrophobic C18 analytical
column compared with SYWKQCAFNAVSCFamide.
Table 3. Target Peptide Sequences, Masses, and Single, Doubly, and Triply Charged
State Mass-to-Charge (m/z) Ratios
Peptide Name
AST-C

AST-C reduced
a
b

Sequence (possible
protonation sites in bold)a

Mass [M]
(Da)b

Expected mass-to-charge ratios, m/z
[M+H+]+ [M+2H+]2+/2 [M+3H+]3+/3

pQIRYHQCYFNPISCF

1898.8234

1899.831

950.419

633.948

*SYWKQCAFNAVSCFamide

1649.712

1650.719

825.863

550.911

pQIRYHQCYFNPISCF

1900.838

1901.845

951.426

634.620

*SYWKQCAFNAVSCFamide

1651.727

1652.734

826.871

551.583

Asterisk indicates possible protonation at the N-terminal amine group
Monoisotopic mass
Although MS analysis does not indicate specific protonation sites, probable sites

for protonation were predicted and are shown in bold in Table 3. Basic amino acid
residues as well as unblocked N-termini were expected to be protonated. Both peptides
were expected to be protonated at two sites: pQIRYHQCYFNPISCF at the two basic
residues (Arg3 and His5) and SYWKQCAFNAVSCFamide at the N-terminus and the
basic Lys4 residue. For both target peptides, the doubly-charged ion was most abundant,
as expected. Furthermore, for pQIRYHQCYFNPISCF, the measured m/z of 950.924
matched the theoretical m/z for the doubly-protonated peptide (Fig. 8B and Table 3).
There were also significantly less intense peaks matching the singly- and triply-charged
states. Similarly, the most abundant m/z peak for SYWKQCAFNAVSCFamide (m/z
825.866) matched the theoretical m/z for the doubly-protonated peptide (Fig. 8D and
Table 3). A dramatically less intense peak matching the triply-charged state mass for
pQIRYHQCYFNPISCF was also observed.
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B

pQIRYHQCYFNPISCF
Counts

Counts

A

C SYWKQCAFNAVSCFamide

pQIRYHQCYFNPISCF
[M+3H+]3+
633.948

[M+2H+]2+
950.924

Counts

Counts

D SYWKQCAFNAVSCFamide
[M+2H+]2+
825.866

Fig. 8. Chromatograms and MS spectra for pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide. (A) Chromatogram for pQIRYHQCYFNPISCF,
showing elution at 7.02 min. (B) MS spectrum for pQIRYHQCYFNPISCF shows
[M+2H+]2+ ion with m/z 950.924 was most abundant. (C) Chromatogram for
SYWKQCAFNAVSCFamide, showing elution at 6.37 min. (D) MS spectrum for
SYWKQCAFNAVSCFamide shows [M+2H+]2+ ion with m/z 825.866 was most
abundant.
To determine how the disulfide bond influenced chromatographic retention and
mass spectral properties, the reduced forms of pQIRYHQCYFNPISCF and
SYWKQCAFNAVSCFamide were generated. For both peptides, the reduced form eluted
later than the oxidized, disulfide-bonded peptide (Fig. 9A). The increase in retention for
the reduced peptide may result from the peptide being able to assume a more linear form
with stronger interactions with the stationary phase. The MS spectra showed the expected
mass shifts from the addition of two hydrogen atoms; the [M+2H]2+ was the most
abundant charge state for both reduced peptides (data not shown).
Although these MS peaks matched theoretical m/z values, peptide masses are
insufficient to confirm amino acid sequences. Therefore, MS/MS data are needed to
verify peptide identity. Using the known total peptide mass, differences between MS/MS
fragment m/z values that corresponded to the m/z value of a particular amino acid residue
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revealed where that amino acid was in the overall sequence. By compiling these fragment
m/z values, the total sequences for both peptides were confirmed.

SYWKQCAFNAVSCFamide

SYWKQCAFNAVSCFamide

B

C

Fig. 9. LC-MS/MS characterization of SYWKQCAFNAVSCFamide
standard and SYWKQCAFNAVSCFamide. (A) SYWKQCAFNAVSCFamide
eluted at 18.39 min and SYWKQCAFNAVSCFamide eluted slightly later at
19.24 min. (B) MS/MS spectrum collected for sequence confirmation. Peptide
structure shown at top. Ions and residues shown in red were detected by MS/MS
analysis. SYWKQCAFNAVSCFamide was mostly fragmented at sites outside the
disulfide bond. (C) SYWKQCAFNAVSCFamide (reduced) allowed for
fragmentation at many sites, as shown in red in the structure at the top.
MS/MS data were collected in order to characterize and confirm the sequences of
oxidized SYWKQCAFNAVSCFamide (Fig. 9B) and reduced
SYWKQCAFNAVSCFamide (Fig. 9C) forms. For MS/MS analysis, the abundant
[M+2H]2+ precursor ion was selected by the quadrupole mass filter and was dissociated
in the collision cell. The product ions identified in the MS/MS spectra (Fig. 9) include y-
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type ions, which include the C-terminus of the peptide, and b-type ions, which include
the N-terminus. Low mass immonium ions, which are characteristic of different amino
acids present in the sequence, appear at low mass and are identified by the one-letter
amino acid codes.
The oxidized SYWKQCAFNAVSCFamide peptide was mostly fragmented at
sites outside the disulfide bond and very little fragmentation was observed at sites
between the cysteine residues (Fig. 9B). However, the reduced form of this peptide was
highly fragmented at many sites and the mass spectrum showed evidence of most of the
amino acid sequence. This suggested that the disulfide bond provided structural stability
that prevented fragmentation. In the oxidized peptide, the breakage of a bond between the
two cysteine residues would not produce fragmentation because the unbroken disulfide
bond would keep the peptide intact. Similarly, breaking the disulfide bond without
breaking a peptide bond would not produce any fragmentation. That is, in order for
SYWKQCAFNAVSCFamide to fragment at a site between the cysteine residues, both
the disulfide bond and a peptide bond must be broken. Therefore, few ions formed by
fragmentation at sites between the cysteine residues were detected. Reducing the
disulfide bond facilitated internal fragmentation, as supported by MS/MS data (Fig. 9C).
MS/MS data for pQIRYHQCYFNPISCF also showed high characteristic fragmentation
outside the disulfide-bonded cysteine residues (data not shown).

3.2 Detection limit assessment in sample matrix
To evaluate detection limits, an eyestalk extract was used as a sample matrix and
was spiked with increasing concentrations of target peptides to mimic the behavior of a
biological tissue extract. To prepare the extract, an eyestalk ganglion was extracted into
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an acidified methanol solvent. The tissue was heated at 100°C to denature enzymes that
would attack the target peptides and was then homogenized and sonicated to release
biological material into the extraction solvent (Stemmler et al., 2013). The sample was
centrifuged to remove insoluble material and the supernatant was filtered to further
eliminate insoluble contaminants. The diluted solution showed no
pQIRYHQCYFNPISCF peptide signals.
Each peptide-spiked tissue extract was analyzed by LC-MS, chromatographic
peaks were integrated, and peak area was plotted as a function of peptide concentration
(Fig. 10). pQIRYHQCYFNPISCF showed higher signal-to-concentration linearity (R2 =
0.996) than SYWKQCAFNAVSCFamide (R2 = 0.802), but both relationships were fairly
linear. Based upon the 0.5 µL injection volume, the minimum amount of peptide detected
was 25 fmol for pQIRYHQCYFNPISCF and 5.0 fmol for SYWKQCAFNAVSCFamide.
This provided reassurance that when quantifying peptide levels, a linear calibration curve
could be used to reliably determine the concentration of peptide present in a sample with
a given target peptide signal intensity.
For a given change in peptide concentration, signal intensity increased more for
pQIRYHQCYFNPISCF than for SYWKQCAFNAVSCFamide. This is indicated by the
greater slope for the pQIRYHQCYFNPISCF regression line and suggested that this
peptide is more easily ionized and detected. Arg3 is the most basic amino acid and is
contained in pQIRYHQCYFNPISCF, thereby making its affinity for protonation higher
than that of SYWKQCAFNAVSCFamide. In contrast, SYWKQCAFNAVSCFamide
only has two probable protonation sites at the N-terminus and the less basic Lys4 residue.
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Fig. 10. Peak area vs. peptide concentration for
pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide in sample
matrix. Both relationships were linear (R2 < 0.99 for
pQIRYHQCYFNPISCF and R2 = 0.80 for SYWKQCAFNAVSCFamide.
Minimum amount of peptide detected was 25 fmol
pQIRYHQCYFNPISCF and 5.0 fmol SYWKQCAFNAVSCFamide.
3.3 Peptide detection in PO and eyestalk
To determine if target peptides could be detected in a tissue extract, PO and
eyestalk tissues from H. americanus were analyzed by LC-MS. pQIRYHQCYFNPISCF
was detectable in a single PO extract. The chromatogram for the most abundant charge
state of pQIRYHQCYFNPISCF showed an intense signal at 6.905 min (Fig. 11A). At
this retention time, MS data shows an abundant doubly-charged ion with m/z 950.419 and
a low-intensity singly-charged ion with m/z 1899.831 (Fig. 11B). MS/MS data (not
shown) confirmed the identity of pQIRYHQCYFNPISCF. Neither MS nor MS/MS data
showed evidence of the reduced form in this biological sample. Other abundant masses
corresponded to peptides common to crustaceans including orcokinins, SIFamide,
CPRPs, and crustacean hyperglycemic hormone (CHH) (Christie et al., 2010; Hui et al.,
26

2011). Confirming the detection of pQIRYHQCYFNPISCF in a single PO extract gave
confidence that quantification of very small peptide amounts was feasible; however, this
analysis also highlighted challenges associated with the analysis.
A

B

Fig. 11. pQIRYHQCYFNPISCF detection in PO. (A) Total ion
chromatogram (green) and extracted ion chromatogram (red) for expected
most abundant m/z. Scaled to largest peak in each chromatogram. (B) MS
data at peptide retention time showed an abundant doubly-charged ion
with m/z 950.419 and an additional low-intensity peak for a singlycharged ion with m/z 1899.831. Contaminant peak shown has been seen in
previous work and is known to coelute with pQIRYHQCYFNPISCF (E.
Stemmler, unpublished data).
Some of these challenges included high levels of sample contamination (see total
ion chromatogram in Fig. 11A showing many non-peptide peaks), most significantly
phospholipids that can interfere with analysis. Variable peptide signal intensities may be
associated with phospholipid contamination, dissection techniques, time of dissection,
homogenization, or adsorptive losses. Specifically, when analyzing PO and eyestalk
extracts, there seemed to be significant variability in crustacean peptide signal intensities.
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There appeared to be no substantial signal intensity discrepancies between eyestalk
extracts prepared by manual or motorized tissue homogenization or between dissections
times of 10 min (short) and 20 min (long). Previous research has shown evidence that
circadian rhythm in crayfish controls peptide manufacturing. Crustacean hyperglycemic
hormone (CHH) levels are especially influenced by these patterns (Fanjul-Moles et al.,
2010). Therefore, it is possible that neuropeptide expression patterns in H. americanus
vary throughout the day. In addition, physiological conditions also affect peptide
manufacturing (Strauss and Dircksen, 2010; Hou et al., 2012). In future experiments,
these factors should be controlled for by extracting tissues at roughly the same times of
day.
3.4 Delipidation
Phospholipids are known to hinder peptide ESI protonation, thereby interfering
with peptide detection in biological samples (Van Eeckhaut et al., 2009). Since
chloroform effectively dissolves large phospholipids and not peptides, it has served as a
successful medium for removing lipids from aqueous tissue extracts (Folch et al., 1957).
To determine if a micro liquid-liquid extraction with chloroform could be used to extract
phospholipids from tissue extracts, a tissue extract was analyzed before and after
chloroform extraction. The chloroform-methanol extraction successfully extracted lipids
from neuropeptide material. Phospholipid signal intensity was much less when the
chloroform extraction was performed, suggesting successful delipidation. However, there
was essentially no difference in crustacean peptide signal intensity between samples.
Furthermore, white precipitate formed upon extraction, raising concerns about sample
loss. Therefore, this approach was not pursued as a useful method to improve peptide
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recovery or detection. Whereas this technique involves liquid-liquid extraction, another
student tested solid phase extraction using C18 spin columns for delipidation. The
hydrophobic phospholipids should partition into the C18 stationary phase to separate
components from other peptides. This may be a more effective alternative that will be
explored in future experiments.
3.5 Internal standard selection and characterization
To quantify pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide,
[Arg8]vasotocin, [Lys8]vasopressin, [Arg8]vasopressin, and oxytocin were selected as
potential internal standards. These internal standard sequences and masses are presented
in Table 4, with basic residues and likely protonation sites shown in bold. These are noncrustacean neuropeptides not found in H. americanus. Due to the disulfide bond linking
the cysteine residues in each internal standard, these peptides were expected to behave
similarly to the target peptides. That is, any loss of pQIRYHQCYFNPISCF or
SYWKQCAFNAVSCFamide due to heat treatment, loss to tubes or pipet tips during
transfers, or losses when extracting or filtering, for instance, was also expected to affect
the selected internal standards. The amidated C-terminus of each internal standard
suggested they would behave especially similarly to SYWKQCAFNAVSCFamide.
Therefore, [Arg8]vasotocin, [Lys8]vasopressin, [Arg8]vasopressin, and oxytocin were
expected to serve as appropriate recovery references for quantification.
In the initial steps of quantification method development, the internal standards
were characterized by LC-MS/MS as individual components and as mixtures of multiple
standards. For all four internal standards, MS data showed that the doubly-charged ion
was most abundant. This suggests each peptide was protonated at the unblocked N-
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terminus. [Arg8]vasotocin and [Arg8]vasopressin were likely protonated at Arg8, the most
basic amino acid, and [Lys8]vasopressin at the Lys8, another highly basic amino acid. The
most likely second protonation site on oxytocin is Pro7 (Moret and Zebende, 2007).
When the four peptides were mixed together at equal concentrations of 10 µM and
analyzed by LC-MS, they were chromatographically separated, as shown in Fig. 12.
Table 4. Internal Standard Sequences, Masses, and Single, Doubly, and Triply Charged
State Mass-to-Charge (m/z) Ratios
Peptide Name
[Arg8]vasotocin
[Lys8]vasopressin
[Arg8]vasopressin
oxytocin
a
b

Sequence (possible
protonation sites in bold)a

Mass [M]
(Da)b

Expected mass-to-charge ratios, m/z
[M+H+]+ [M+2H+]2+/2 [M+3H+]3+/3

*CYIQNCPRGamide

1049.455

1050.462

525.735

350.826

*CYFQNCPKGamide

1055.433

1056.440

528.724

352.818

*CYFQNCPRGamide

1083.439

1084.446

542.727

362.154

*CYIQNCPLGamide

1006.438

1007.445

504.226

336.487

Asterisk indicates possible protonation at the N-terminal amine group
Monoisotopic mass
[Lys8]vasopressin
Oxytocin
8

[Arg8]vasotocin

[Arg ]vasopressin

Fig. 12. EIC overlays for internal standard mixtures. All standards
were at equal concentrations of 10 µM. The peak heights were scaled to
the same value to show chromatographic peak shapes.
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Because AST-C concentrations in tissue extracts may vary significantly, a multilevel internal standard calibration approach was defined. This requires mixtures of the
four internal standards that each differ by an order of magnitude. In mixtures containing
the highest concentrations, we expected that the more abundant peaks would be
overloaded and unsymmetrical, and needed to ensure that these peaks did not interfere
with lower concentration standards. In evaluating the appropriate internal standard
concentration levels, mixtures with symmetric peptide chromatographic peaks for the
peptide being used as the appropriate internal standard would be most reliable for
quantification. In addition, target peptide chromatographic peak areas should be within
the range of that of the internal standard peak areas. Having some internal standards elute
before and some after the target peptides would also be ideal (Hou et al., 2012).
To evaluate how concentration changes impacted peak shapes, four internal
standard mixtures were prepared and analyzed by LC-MS (Fig. 13). Mixtures #1 and #2
(Table 2) showed undesirable asymmetric chromatographic peaks for standards in high
concentrations caused by column overloading. Mixture #3 showed symmetric
chromatographic peaks and the three most concentrated internal standards were easily
detectable. Since [Lys8]vasopressin and [Arg8]vasopressin elute at similar times, a
combination of one of these two peptides, [Arg8]vasotocin, and oxytocin would offer
most reliable quantification.
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2 3

4 Mixture #1

10 M (1)
-6
10 M (2)
-7
10 M (3)
-8
10 M (4)

10-4 M (2)
10-5 M (3)
10-6 M (4)

1
-4

1 23

23

4

Mixture #2

10 M (1)
-5
10 M (2)
-6
10 M (3)
-7
10 M (4)

Mixture #3

-5

4

1 23

Mixture #4

-6

10 M (1)
-7
10 M (2)
-8
10 M (3)
-9
10 M (4)

Fig. 13. Chromatogram overlays for internal standard mixtures. The
peak heights were scaled to the same value to show chromatographic peak
shapes. Standards are labeled (1) [Arg8]vasotocin, (2) [Lys8]vasopressin,
(3) [Arg8]vasopressin, and (4) oxytocin. Adapted from a figure provided
by E. Stemmler.
3.6 Internal standard mixtures with target peptides showed evidence of analyte loss
The target peptides, pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide,
were then mixed with these internal standards for further chromatographic analysis. For a
solution of 10-4 M [Arg8]vasotocin, 10-5 M [Lys8]vasopressin, 10-6 M [Arg8]vasopressin,
and 10-7 M oxytocin with 10-5 M of each target peptide, the target peptide signals were
comparable in intensity to that for 10-4 M [Arg8]vasotocin (10 times more concentrated),
suggesting that the target peptides had a higher nanoESI ionization efficiency. The
mobile phase gradient was optimized to minimize chromatographic peak overlap between
the target peptides and internal standards. Using the optimized gradient, [Arg8]vasotocin
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eluted earliest followed by [Lys8]vasopressin, [Arg8]vasopressin, and oxytocin,
respectively. The target peptides eluted later in the chromatogram than the internal
standards (data not shown).
To investigate relative signal intensities as a function of concentration, several
standard mixtures of a single internal standard, [Arg8]vasotocin, mixed with
SYWKQCAFNAVSCFamide and pQIRYHQCYFNPISCF were characterized. However,
there were inconsistencies in signal strengths for the target peptides. For example, a 10
µM mixture of the target peptides and [Arg8]vasotocin showed saturated signals for the
two target peptides at this high concentration (Fig. 14A), while a 10-fold dilution of this
solution showed SYWKQCAFNAVSCFamide and pQIRYHQCYFNPISCF peaks that
were approximately 40 and 500 times lower in response, respectively (Fig. 14B).
Multiple replicates showed that upon an additional 10-fold dilution, the peptides were
undetectable. These decreases in signal strength are far greater than the approximate 10fold decrease that would be conventionally expected.
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A 10 µM

SYWKQCAFNAVSCFamide

pQIRYHQCYFNPISCF

[Arg8]vasotocin

B 1 µM

[Arg8]vasotocin

SYWKQCAFNAVSCFamide

pQIRYHQCYFNPISCF

Fig. 14. Target peptide signal losses upon sample dilution. (A) A 10
µM solution yields saturated signals for the two target peptides. (B) Upon
10-fold dilution of this solution, SYWKQCAFNAVSCFamide and
pQIRYHQCYFNPISCF peaks were approximately 40 and 500 times
lower in response, respectively.
All of these disproportionate losses in relative signal strength suggested possible
peptide adsorption to the sample vial walls that was dependent on relative concentrations.
During initial work directed at characterizing the target peptides, greater-than-expected
losses of AST-C peptide signals were found following serial dilutions. For example,
when pQIRYHQCYFNPISCF serial dilutions were prepared in standard plastic tubes
before being transferred to polypropylene vials for analysis, chromatographic peaks
decreased more dramatically than the expected dilution factor. In contrast, when dilutions
were prepared directly in polypropylene LC-MS vials, the expected change in signal
intensity was observed (Fig. 15). For the peaks shown in Fig. 15, both samples contained
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10 µM pQIRYHQCYFNPISCF in water and 0.5 µL of each was injected for analysis.
Therefore, the signals for the target peptide were expected to be equivalent. Contrary to
expectations, the chromatographic peak area for the sample prepared in the
polypropylene vial was about two orders of magnitude larger than that for the solution
prepared in standard plastic (220 x 105 compared to 5 x 105). In contrast,
SYWKQCAFNAVSCFamide did not show similar patterns and there did not seem to be
any substantial sample loss in these early experiments.

Diluted in polypropylene

Diluted in standard plastic

Fig. 15. pQIRYHQCYFNPISCF sample loss. In this chromatogram
overlay, 10 µM of solution prepared directly in polypropylene vials
showed a much more intense signal (peak area 2 x 107) than for a solution
of equivalent peptide concentration and injection volume prepared from a
serial dilution in standard plastic tubes (peak area 5 x 105).
In this early work, it was hypothesized that this signal loss was due to the affinity
of the peptide to the walls of the standard plastic vials. Previous studies have shown that
some peptides exhibit this behavior when stored in glass or standard plastic, which can
contribute to significant sample loss (Kraut et al., 2009). After observing such loss, all
samples were prepared in low-retention plastic tubes to prevent peptide adsorption in
standard plastic tubes. Furthermore, 25% acetonitrile (ACN) was included in dilution
solvents to help prevent adsorptive losses. Such use of organic solvent has been shown to
improve signal-to-concentration linearity (Warwood et al., 2013). In the present study,
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we expected that diluting samples in organic solvent in low-retention tubes would prevent
peptide loss. However, analyte loss was still observed in subsequent experiments. This
led to a more detailed investigation of the causes of peptide signal loss.
3.7 Factors that may lead to analyte loss
Before proceeding with the development of a method for peptide quantification,
the sources of these signal losses needed to be identified. Due to repeated evidence of
sample loss, the focus of this study shifted to addressing factors leading to analyte loss.
Factors that have been shown to negatively impact signal recovery include adsorptive
losses to analysis vial walls, pipette tips, and various parts within the LC-MS instrument
due to hydrophobic, hydrophilic, or electrostatic interactions between the analyte and
adsorptive surface. Previous work has shown that at low concentrations, signal strength is
highly compromised because a substantial proportion of peptide present is adsorbed. This
can make the analyte barely detectable. At high concentrations, sample loss to adsorption
is less drastic relative to the amount of peptide in solution (Maes et al., 2014). Since such
research suggested that vial material could compromise signal recovery, a more rigorous
systematic analysis of potential causes of these losses was performed in the present study.
3.8 Analyte loss to sample vials
To test whether loss was affected by analysis vial material, solutions of
[Arg8]vasotocin and the target peptides at equal concentrations of 10-6 M were diluted
directly into either a low-retention polypropylene or glass vial. Chromatography showed
a dramatic reduction in pQIRYHQCYFNPISCF signal intensity when using
polypropylene (Fig. 16A) compared to glass (Fig. 16B). These results were consistent
with a previous study finding that glass is preferred for storing hydrophobic peptides
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(Van Midwood et al. 2007). pQIRYHQCYFNPISCF contains hydrophobic residues (one
Pro, two Ile, and two Phe residues) and elutes at a late retention time, suggesting that this
is a particularly hydrophobic peptide. Ultimately, the results of the present study
suggested that vial material affected signal recovery and that glass was preferred over
polypropylene for detecting hydrophobic peptides.
A

SYWKQCAFNAVSCFamide

8

[Arg ]vasotocin
pQIRYHQCYFNPISCF
analyzed in polypropylene

SYWKQCAFNAVSCFamide

8

B [Arg ]vasotocin

SYWKQCAFNAVSCFamide
pQIRYHQCYFNPISCF
analyzed in glass

SYWKQCAFNAVSCFamide

Fig. 16. Evidence of SYWKQCAFNAVSCFamide reduction and
pQIRYHQCYFNPISCF sample loss. (A) Low intensity signal for
pQIRYHQCYFNPISCF when prepared in plastic. (B)
pQIRYHQCYFNPISCF signal recovered when prepared in glass. Scaled
to largest peak in each chromatogram.
However, hydrophobicity alone is not sufficient to explain why the
pQIRYHQCYFNPISCF peak was most intense for the preliminary six-peptide mixture
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(four internal standards and both target peptides) and least intense for the three-peptide
mixture ([Arg8]vasotocin and both target peptides). In the six-peptide mixture,
[Arg8]vasotocin was 10 times more concentrated than the target peptides (10-5 M),
making it possible that this internal standard occupied most of the adsorptive sites on the
polypropylene vial walls. In contrast, for the three-peptide mixture, [Arg8]vasotocin and
the target peptides were at equal concentrations of 10-5 M. Here, as explained by Maes et
al., it is likely that the most hydrophobic peptide was unhindered by a more concentrated
species from binding to the adsorptive sites. This suggests that adsorption may be
concentration-dependent.
3.9 Prewashing analysis vials for signal recovery
In addition to vial material, contaminants or coatings inside the vials could have
caused adsorptive losses. To test this, prewashing polypropylene and glass vials with
water, 25% ACN, and isopropanol was explored as a way to eliminate unwanted
contaminants. Across replicate experiments, prewashing polypropylene vials with
isopropanol showed greater pQIRYHQCYFNPISCF signal recovery than any other
treatment (Fig. 17). That is, the mean prewash-to-no prewash ratios were significantly
higher for the isopropanol-washed polypropylene treatment than all other conditions
(ANOVA, N = 2). These results suggested that prewashing polypropylene vials with
isopropanol successfully conserved hydrophobic peptide signal intensity, possibly
because isopropanol washed away any hydrophobic contaminants on the polypropylene
vial walls.
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Fig. 17. Prewash-to-no prewash ratios of pQIRYHQCYFNPISCF
peak areas. 1 µM pQIRYHQCYFNPISCF analyzed in (A) polypropylene
and (B) glass vials prewashed in H2O, 25% ACN, and isopropanol.
Prewash-to-no prewash ratio for isopropanol-washed polypropylene was
significantly higher than the remaining treatments (ANOVA, N = 2).
There were no significant differences between prewash-to-no prewash
ratios for the other conditions (ANOVA, N = 2 for each condition).
Peptide standard solutions diluted using isopropanol-washed low-retention tubes
and pipette tips did not have any apparent effect on pQIRYHQCYFNPISCF signal
recovery. Sonication of samples before analysis also did not increase signal intensity
(data not shown). Isopropanol-washed polypropylene vials were used for all subsequent
experiments.
3.10 No initial evidence for sample loss within the instrument when varying
injection volumes at constant peptide concentration
To test whether loss occurred within the instrument during analysis, injection
volume was varied at constant peptide concentration. Loss at this point in the analysis
could result from adsorptive losses to surfaces including, but not limited to, the injection
needle, column, tubing, and mass spectrometer. Especially basic peptides can stick to
metal surfaces while hydrophobic peptides tend to stick to plastic surfaces.
pQIRYHQCYFNPISCF is particularly hydrophobic and contains basic residues, making
39

it prone to such losses. Any instrument loss would compromise the signal-to-injection
linearity, especially at low concentrations where adsorptive losses are most evident (Maes
et al., 2014).
A preliminary experiment showed that increasing injection volumes of the same
peptide sample yielded pQIRYHQCYFNPISCF signals that increased linearly. Multiple
injections of 1 µM pQIRYHQCYFNPISCF analyzed in isopropanol-washed
polypropylene vials showed that the relationship between peak area and the amount of
peptide injected was strongly linear, suggesting that sample loss in the instrument during
analysis was negligible (Fig. 18). If there were sample loss here, signals for small
injection volumes would be compromised. Greater injection volumes would be less
affected because the amount of sample lost would be negligible compared to the amount
of peptide injected. This would decrease the signal-to-injection volume linearity.
However, these results showed that sample loss within the instrument did not affect
peptide detection.
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Fig. 18. pQIRYHQCYFNPISCF peak area vs. volume of 1 µM peptide
injected. The relationship between pQIRYHQCYFNPISCF peak area and
injection volume was strongly linear (R2 > 0.99).
3.11 More in-depth investigation of concentration-dependent losses
In addition to the internal standard mixture analyses discussed in Sections 3.5 and
3.6, other preliminary data showed evidence of potential concentration-dependent signal
loss. Signal intensity for a given molar amount of peptide injected was not expected to
change between samples regardless of initial concentration. That is, signal intensity was
expected to be the same when injecting 0.1 µL of 1 µM peptide and 1.0 µL of 0.1 µM
peptide because 100 fmol of peptide was injected in both conditions. Contrary to this
prediction, pQIRYHQCYFNPISCF was detectable from a 0.1 µL injection of 1 µM
peptide (Fig. 19A), but was nearly undetectable from a 1.0 µL injection of 0.1 µM
peptide (Fig. 19B). Since the same amount of peptide should have been injected in both
conditions, these results suggested signal loss was concentration-dependent. This led to
further exploration of the potential causes for this observed signal loss by analyzing
additional peptides that differed in size and hydrophobicity.
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A

B
no signal

Fig. 19. EICs for 100 fmol pQIRYHQCYFNPISCF injections. (A) 0.1
µL injection of 1 µM peptide and (B) 1.0 µL injection of 0.1 µM peptide
were injected. pQIRYHQCYFNPISCF was detected from the 1 µM
solution, but not the 0.1 µM solution.
3.12 Signal loss dependence on peptide size and hydrophobicity
Mixtures of seven peptides varying in size and hydrophobicity were characterized
to determine whether signal loss was dependent on concentration or peptide-specific
properties (Table 5 and Fig. 20). These peptides were selected based on availability,
retention time, and chromatographic resolution. RTVGGFA, RAAFGFA, and RTVFGFA
were relatively small in size and contained between three and five hydrophobic residues.
AST-B and AFDEIDRSGFGFA were slightly larger in size and contained five and six
hydrophobic residues, respectively. CLDH was very large and hydrophobic compared to
the other peptides, including pQIRYHQCYFNPISCF. In conjunction with the proportion
of hydrophobic residues, retention time was used as the primary determinant of peptide
hydrophobicity. The peptides that eluted latest were classified as most hydrophobic
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because they interacted most favorably with the hydrophobic stationary phase.
pQIRYHQCYFNPISCF appeared to be most difficult to detect (smallest peak area) and
eluted latest.
Table 5. Peptide Sequences, Most Abundant m/z, and Retention Times

AST-C

1898.8230

950.4190

Name

RAAFGFA
AST-B
RTVFGFA
AFDEIDRSGFGF
A

AST-B

pQIRYHQCYFNPISCF

CLDH

Mass (Da)a
706.3761
738.3812
1265.5940
796.4231
1430.6470
2939.5190

Most
abundant
m/z
354.1954
370.1979
633.8044
399.2188
716.3306
735.8870

CLDH

Sequence
(hydrophobic residues in
bold)
RTVGGFA
RAAFGFA
TNWNKFQGSWamide
RTVFGFA
AFDEIDRSGFGFA
GLDLGLGRGFSGSQAAKH
LMGLAAANFAGGPamide
21.7
pQIRYHQCYFNPISCF
a
Monoisotopic mass

RTVGGFA

Retention
time
(min)
9.8
13.8
14.8
15.6
17.3
20.1

Fig. 20. Merged EIC of seven peptides in sample loss analysis.
Chromatogram shows retention times and relative signal intensity of the
seven peptides.
A mixture of these seven peptides was tested for signal loss at different
concentrations and injection volumes. Concentration was varied to reveal whether any
observed signal loss could be attributed to concentration-dependent sample loss. Injection
volume was manipulated to determine whether any sample loss occurred within the
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instrument. Detected peak areas were plotted as a function of the amount of peptide
injected (Fig. 21); points originating from solutions of different concentrations were
overlayed to determine if the same amount of injected peptide yielded the same peak
area.
The relationship between peak area and the amount of peptide injected was highly
linear for the small peptides: RTVGGFA (Fig. 21A, R2 = 0.99), RAAFGFA (Fig. 21B, R2
= 0.98) and RTVFGFA (R2 = 0.99) for all three solution concentrations (0.4, 0.7 and 1.0
µM). Data for AST-B was also fairly linear (R2 = 0.91). However, this pattern was not
observed for the later eluting peptides, including CLDH (Fig. 21C) and
pQIRYHQCYFNPISCF (Fig. 21D), which did not show evidence of strong signal-toinjection linearity.
The signal-to-injection nonlinearity for the two most hydrophobic peptides
provided strong evidence for concentration-dependent sample losses during LC-MS
analysis, with more analyte being lost when smaller injection volumes were used. In
addition to the curvature observed as a function of injection volume, CLDH and
pQIRYHQCYFNPISCF behaved differently at each mixture concentration, as shown by
the lower peak areas for equivalent amounts of peptide injected from solutions of
different concentration. This suggested that concentration-dependent sample loss could
also have occurred when the solutions were diluted. For pQIRYHQCYFNPISCF, the
signals were generally very weak or undetectable at 0.4 µM. Notably, CLDH and
pQIRYHQCYFNPISCF are most impacted by the observed peptide loss. These peptides
elute latest, and therefore, are presumably the most hydrophobic.
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Fig. 21. Peak area vs. amount of peptide injected for (A) RTVGGFA, (B)
RAAFGFA, (C) CLDH, and (D) pQIRYHQCYFNPISCF. This relationship
was highly linear for this RTVGGFA (R2 = 0.99) and RAAFGFA (R2 = 0.98).
However, these curves were fit to second order polynomials for CLDH and
pQIRYHQCYFNPISCF. Injection volumes varied from 0.01–1.3 µL of sevenpeptide mixtures varying from 0.4–1 µM in concentration.
pQIRYHQCYFNPISCF was not detected at 0.4 µM.
We also compared these most recent data with earlier experiments that showed a
linear relationship between pQIRYHQCYFNPISCF signal intensity and injection volume
(Fig. 18). This discrepancy could have been influenced by factors such as samples run
before performing these experiments that lingered in the instrument and interfered with
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peptide detection. Nonetheless, this more extensive experiment testing multiple peptides
at various concentrations and injection volumes showed convincing evidence of
instrument loss for more hydrophobic peptides, which led to further investigation of
techniques to reduce such losses.
3.13 Signal recovery in solution with PEG
Diluting peptide samples in polyethylene glycol (PEG, 0.001%) has previously
been shown to increase signal recovery of various peptides by reducing adsorptive losses
(Stejskal et al., 2013). This sample treatment was explored for solutions containing
pQIRYHQCYFNPISCF. Consistent with the findings of Stejskal and colleagues, PEG
successfully increased signal recovery for the peptide of interest, pQIRYHQCYFNPISCF
(Fig. 22). pQIRYHQCYFNPISCF absolute peak areas for samples diluted in water were
generally weak compared to those diluted in 0.001% PEG in water (Fig. 22A). There was
a much greater difference in absolute peak area for the solutions at higher concentration
(0.7 µM); however, the relative increase in peak area was much greater for solutions at
the lower concentration (0.4 µM) (Fig. 22B). This suggested that PEG had a greater
effect on signal recovery at lower concentrations. This is consistent with findings in both
the present study and previous research showing that adsorptive losses most significantly
affect solutions at low concentrations, whereas solutions at higher concentrations are less
impacted.
In contrast, dilution in 0.001% PEG generally showed moderately decreased
signal recovery for the remaining peptides at concentrations of 0.1, 0.4, and 0.7 µM, with
the exceptions of AST-B at 0.4 µM and RTVFGFA at 0.1 µM (data not shown).
Therefore, PEG may have interfered with the detection of these smaller, more hydrophilic
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peptides while enhancing signal recovery of pQIRYHQCYFNPISCF. Nonetheless, this
served as a potential technique for analyzing hydrophobic peptides at low concentrations.
A

PEG

No PEG

Peak area (x 106)

20

15
10
5
0

Concentration; injection volume
B
PEG/no PEG ratio

100
75
50
25
0

Amount Injected (fmol)
Fig. 22. Peak area vs. amount of pQIRYHQCYFNPISCF injected
with and without 0.001% PEG in solution. (A) Adding 0.001% PEG
increased absolute pQIRYHQCYFNPISCF peak areas most for samples at
higher concentrations. (B) PEG-to-no PEG signal ratios were highest at
low concentrations. Injection volumes varied from 0.05–1.0 µL of 0.1–1
µM solutions.
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Although PEG successfully increased signal recovery for hydrophobic peptides,
biological samples contain a broad range of peptides that vary greatly in size,
hydrophobicity, and other properties. Therefore, optimizing detection of one category of
peptide would prevent accurate quantification of other types of peptides. Moreover,
peptides are found at very low concentrations in biological samples and their detection
requires high sensitivity. However, results showed that signal recovery is most highly
compromised for low analyte concentrations. Ultimately, the present study demonstrated
that in order to minimize analyte loss, factors such as adsorptive losses during sample
preparation and analysis that are especially problematic for hydrophobic peptides must be
addressed.
FUTURE WORK
The source of peptide signal loss and techniques for signal recovery must be
optimized in order to allow for successful peptide quantification in biological samples.
Overall, the results of the present study show that there are likely multiple sources of
sample loss, including adsorptive losses to vials and LC-MS components that most
drastically affect hydrophobic peptides at low concentrations.
In the future, PEG should be tested as a prewash for analysis vials that would coat
adsorptive sites on the vial walls without interfering with peptides in solution. More
extensive experiments should be performed to analyze the target peptides across broader
concentration ranges and injection volumes in continued effort to identify the conditions
under which signals are most highly compromised. This will also help determine whether
signal loss is primarily a function of peptide concentration, size, hydrophobicity, or other
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factors such as temperature, which can particularly affect the detection of hydrophobic
peptides (Maes et al., 2014).
After developing a method for optimal sample preparation, attention can be
redirected at the goal of peptide quantification in biological samples by a multipoint
internal standard mixture. This would involve determining the amount of internal
standard that must be added at the beginning of the extraction process in order to recover
the amounts that give the desired chromatographic signal intensity. This could be done
experimentally by adding known concentrations of the internal standards to the extraction
solvent before tissue removal from the animal. Following peptide extraction, the sample
could be analyzed to determine the amount of internal standard and analyte recovered.
Since the target peptides are found in very low concentrations in the eyestalk and PO, the
number of tissues that might need to be pooled to detect the desired amount of peptide
also must be determined experimentally. By pooling the desired number of tissues and
adding the appropriate amount of internal standard, it would be possible to quantify the
amount of target peptide in a single tissue.
Other future directions of this study could include identifying other modified and
unmodified forms of pQIRYHQCYFNPISCF and SYWKQCAFNAVSCFamide. This
information could be coupled with biological analyses to determine which forms are
bioactive. Currently, there is little known information about how post-translational
modifications contribute to bioactivity. This research will contribute to efforts to clarify
the role of post-translational modifications in bioactivity and to identify differences
between the functions of the structurally similar AST-C peptides. Above all, this
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knowledge will help explain neuropeptide interactions and their influence on behavior in
crustaceans and more complex systems.
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APPENDIX I: COLOR FIGURES IN GRAYSCALE

Fig. 2B. Disulfide bond formation between two cysteine residues.

Fig. 3. Crustacean nervous system.
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Fig. 4. Target peptide visualization in the PO.

Fig. 6B. Schematic diagram of Q-TOF mass analyzer. Adaped from Vollmer et al. 2011.
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Fig. 7. Peptide quantification by internal standard.

Fig. 9B and C. LC-MS/MS characterization of SYWKQCAFNAVSCFamide standard
and SYWKQCAFNAVSCFamide.

Fig. 11. pQIRYHQCYFNPISCF detection in PO. (A) Total ion chromatogram
and extracted ion chromatogram for expected most abundant m/z. Scaled to
largest peak in each chromatogram.
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Fig. 16. Evidence of SYWKQCAFNAVSCFamide reduction and sample loss.
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